Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: results from a prospective community oncology study. Procrit Study Group.

Source:http://linkedlifedata.com/resource/pubmed/id/9779721

Download in:

View as

General Info

PMID
9779721